Mitesh J. Borad, M.D.

  1. Oncologist

Location

  1. Phoenix, Arizona

Languages

English
  1. Basal cell carcinoma
  2. Gallbladder cancer
  3. Gastrointestinal stromal tumors
  4. Hepatocellular carcinoma
  5. Liver cancer
  6. Pancreatic cancer
  7. Pheochromocytoma
  • Phase I drug development
  • Pancreatic cancer
  • Biliary cancer (cholangiocarcinoma)
  • Liver cancer (hepatocellular carcinoma)
  • Genomic/novel clinical trial designs
  • Rare cancers: adrenocortical cancer, metastatic basal cell cancer, pheochromocytoma, gastrointestinal stromal tumor (GIST)
  1. 2008
    Research Scholar - Drug Development Scholar/Genomics Medicine ScholarTranslational Genomics Research Institute
  2. 2005
    Fellow - Medical OncologyTulane University School of Medicine
  3. 2003
    Resident - Internal MedicineCedars-Sinai Medical Center
  4. 2000
    MDUniversity of Medicine and Dentistry of New Jersey
  5. 1996
    BS - Biomedical Engineering (summa cum laude)Boston University

Certifications

  1. 2006
    Medical OncologyAmerican Board of Internal Medicine

Awards and honors

  1. 2014
    New Innovator AwardNational Institutes of Health
  2. 2011
    Paul Calabresi Scholar in Clinical-Translational ResearchMayo Clinic
  3. 2003
    Solomon Scholar Research AwardCedars Sinai Medical Center
  4. 1999
    MemberTau Beta Pi, The Engineering Honor Society
  5. 1999
    MemberGolden Key International Honor Society
  6. 1999
    MemberNational Biomedical Engineering Honor Society
  7. 1992
    National Merit ScholarshipCentral Board of Secondary Education

Professional memberships

  1. 2016
    Grant ReviewerCholangiocarcinoma Research Fellowship Program, The Cholangiocarcinoma Foundation
  2. 2016
    Grant ReviewerResearch Proposals, Italian Ministry of Health
  3. 2016 - present
    Vice ChairInternational Cholangiocarcinoma Research Network (ICRN)
  4. 2015 - 2021
    Standing MemberDrug Discovery and Molecular Pharmacology Study Section, National Institutes of Health
  5. 2015
    MemberScientific Advisory Board, Pancreatic Cancer Pipeline Development, Pfizer
  6. 2015
    MemberAcelarin (NUC-1031) Development in Biliary Cancers Scientific Advisory Board, Nucana
  7. 2015
    Grant ReviewerCholangiocarcinoma Research Fellowship Program, The Cholangiocarcinoma Foundation
  8. 2014
    MemberScientific Advisory Board, MET Pathway Development Program, Amgen, Inc.
  9. 2014 - present
    MemberCenter for Immunology and Immune Therapies
  10. 2014 - present
    MemberBiomarker Discovery Program
  11. 2014 - present
    MemberHepatobiliary and Pancreatic Cancer Specialty Council, Mayo Clinic Cancer Center
  12. 2014 - present
    MemberBasket/Umbrella Trial Workgroup, Mayo Clinic Cancer Center
  13. 2014 - present
    MemberThe Cancer Genome Atlas (TCGA) Cholangiocarcinoma Analysis Working Group, National Institutes of Health
  14. 2014 - present
    MemberClinical Science Advisory Board, The Cholangiocarcinoma Foundation
  15. 2013 - present
    MemberIndividualized Medicine Clinic Cancer Task Force, Mayo Clinic Center for Individualized Medicine
  16. 2013 - present
    MemberService Line 1 (Cancer) Leadership Team, Mayo Clinic Center for Individualized Medicine
  17. 2013 - present
    MemberGenomics Tumor Board, Mayo Clinic Center for Individualized Medicine
  18. 2012 - 2015
    Founding MemberHepatobiliary Cancer Research Consortium, CanLiv
  19. 2012 - 2015
    Board of DirectorsPancreatic Cancer Research Team, CanLiv
  20. 2012
    MemberScientific Advisory Board, PEGPH20 Pegylated Hyaluronidase Development Program, Halozyme Therapeutics
  21. 2012 - present
    MemberIndividualized Medicine Working Group, Mayo Clinic Center for Individualized Medicine
  22. 2012 - present
    MemberPhase I Administrative Team, Phase I Disease Oriented Group, Mayo Clinic Cancer Center
  23. 2012 - present
    ChairPhase I Disease Working Group, Cancer Clinical Research Office-ARZ
  24. 2010 - 2012
    MemberScientific Review Committee
  25. 2010 - 2012
    MemberScientific Progress Review Subcommittee, Mayo Clinic Cancer Center
  26. 2010 - 2012
    ChairExecutive Committee, Cancer Clinical Research Office-ARZ
  27. 2010 - 2012
    MemberClinical Research Subcommittee, Arizona Research Operations Management Team
  28. 2010 - 2012
    MemberExecutive Committee, Division of Hematology/Oncology, Department of Internal Medicine
  29. 2010 - present
    MemberCancer Center Research Committee-Arizona, Arizona Research Operations Management Team
  30. 2009 - present
    MemberHepatobiliary Cancer Task Force, National Cancer Institute, National Institutes of Health
  31. 2009 - present
    ReviewerSmall Business Innovation Research Grants Meeting, National Institutes of Health
  32. 2008 - 2009
    MemberScientific Review Committee, American Society of Clinical Oncology
  33. 2008
    MemberScientific Advisory Board, Smoothened/Hedgehog Inhibitor Program, Merck & Company Pharmaceutical Company
  34. 2008 - present
    MemberGI Cancer Disease Oriented Group, Mayo Clinic Cancer Center
  35. 2008 - present
    MemberPhase I Disease Oriented Group, Mayo Clinic Cancer Center
  36. 2008 - present
    MemberPancreatic Cancer Management Conference
  37. 2008 - present
    MemberHepatocellular CA Management Conference
See more

Publications

Research activities

See a description of research activities.